Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-06-23

Clinical Trial Results: JARDIANCE® Post Marketing Surveillance in Korean Patients With Chronic Kidney Disease (CKD)

View source ↗

Summary

Post-marketing surveillance study results for JARDIANCE in Korean patients with chronic kidney disease have been completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jardiance (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Kidney Disease, Chronic | Status: COMPLETED | Results posted: 2026-06-23